These special lab-made antibodies grab onto a protein in your blood that messes with cholesterol cleanup, so your body can get rid of bad cholesterol better and lower your chances of heart problems.

1

Pro

0

Against

Evidence from Studies

Supporting (1)

1

Community contributions welcome

1

Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?

Narrative Review

2025 Apr

The study looks at the same cholesterol-lowering drugs mentioned in the claim and finds they work just as described, lowering bad cholesterol by about 60%.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?

Score: 1

DOI: 10.1016/j.pharmthera.2025.108812

Similar Assertions

A type of medicine (like evolocumab or alirocumab) blocks a protein in your body called PCSK9, which helps your liver remove bad cholesterol from your blood—cutting it by about half.

1

0

92%

Blocking a protein called PCSK9 with certain drugs helps your body remove bad cholesterol from your blood more effectively.

63

0

88%

These cholesterol drugs can cut bad cholesterol by half and help prevent heart attacks in people with heart disease, and they’re about as safe as a dummy shot—though some might get a little redness where they’re injected.

1

0

83%

These cholesterol drugs, called PCSK9 inhibitors, probably help lower bad cholesterol in many types of patients — more than fake pills or other cholesterol medicines.

20

0

81%

If you take certain cholesterol-lowering shots like evolocumab or alirocumab every few weeks, they can cut your 'bad' cholesterol by about 60%, even if you're already on cholesterol pills, have a genetic form of high cholesterol, or can't handle statins.

1

0

80%